Does UPADACITINIB Cause Hyperhidrosis? 287 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 287 reports of Hyperhidrosis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.4% of all adverse event reports for UPADACITINIB.
287
Reports of Hyperhidrosis with UPADACITINIB
0.4%
of all UPADACITINIB reports
0
Deaths
83
Hospitalizations
How Dangerous Is Hyperhidrosis From UPADACITINIB?
Of the 287 reports, 83 (28.9%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 287 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which UPADACITINIB Alternatives Have Lower Hyperhidrosis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL